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The activation domains of HIF-1α (residues 776-826) and CITED2 (residues 216-269) utilize partially overlapping binding sites to form high-affinity complexes with TAZ1 ( Fig. 1 ) 5,6, 8, 9 . The α A helices of HIF-1α and CITED2 and their conserved LP(Q/E)L motifs bind to the same surfaces of TAZ1. The region of CITED2 that is C-terminal to the LPEL motif binds in an extended conformation in the same site as the α B helix of HIF-1α . Only the α C helix of HIF-1α binds to a fully non-overlapping site on TAZ1.
Competition between HIF-1α and CITED2 was characterized by NMR spectroscopy. The 1 H- 15 N heteronuclear single quantum coherence (HSQC) spectrum of 15 N-labelled TAZ1 bound to HIF-1α differs from the spectrum of 15 N-TAZ1 bound to CITED2 (Extended Data Fig. 1 ), which allows us to discriminate between HIF-1α -and CITED2-bound TAZ1 resonances and obtain site-specific information on the competition mechanism. Consistent with literature reports 5, 8 , the HIF-1α and CITED2 transactivation domains bind TAZ1 with the same affinity under the conditions of our NMR experiments (dissociation constant (K d ) = 10 ± 2 nM, Extended Data Fig. 2 ). As their binding affinities are the same, we expected that a sample of 15 N-TAZ1 mixed with both the HIF-1α and CITED2 peptides in a 1:1:1 molar ratio would yield an HSQC spectrum with two sets of resonances of approximately equal intensity, corresponding to an equally populated mixture of the 15 N-TAZ1-HIF-1α and 15 N-TAZ1-CITED2 complexes. However, this experiment yielded an unexpected result. Regardless of the order of addition, the only cross peaks observed in spectra of 15 N-TAZ1 samples containing equimolar HIF-1α and CITED2 are those of the binary CITED2 complex ( Fig. 2a , Extended Data Fig. 3 ). Observation of solely the TAZ1-CITED2 complex, despite the equal affinities of HIF-1α and CITED2 for binding to TAZ1, suggests that CITED2 binds to the TAZ1-HIF-1α complex in a strongly cooperative process to fully and efficiently displace HIF-1α at equimolar concentration.
Following the surprising results from the NMR experiments, the interactions of the HIF-1α and CITED2 activation domains with TAZ1 were characterized by fluorescence anisotropy competition experiments 18, 19 . Unlabelled HIF-1α or CITED2 peptide was titrated into a pre-formed complex of AlexaFluor-594-labelled HIF-1α peptide bound to unlabelled TAZ1 (Fig. 2b, c) . As the HIF-1α and CITED2 peptides have equal affinities for TAZ1, the two proteins should behave similarly in displacing fluorescently labelled HIF-1α from the TAZ1 complex. Unlabelled HIF-1α peptide displaces fluorescently labelled HIF-1α from the TAZ1 complex with an apparent K d that is the same as the K d for the binary TAZ1 complex (K d,app HIF-1α = 10 ± 1 nM versus K d, binary = 10 ± 2 nM) ( Fig. 2b) . In contrast, CITED2 is a much more efficient competitor than HIF-1α ( Fig. 2c ), displacing fluorescently labelled HIF-1α from its complex with TAZ1 with an apparent K d of 0.2 ± 0.1 nM, 50-fold smaller than the K d for the binary TAZ1-CITED2 complex (K d, binary = 10 ± 1 nM). Thus, both the fluorescence and NMR results indicate that CITED2 is extremely effective in displacing HIF-1α from the TAZ1-HIF-1α complex. Remarkably, the reverse process is letter reSeArCH 4 4 8 | N a T U r E | V O L 5 4 3 | 1 6 m a r c h 2 0 1 7 inefficient: very high concentrations of HIF-1α peptide are required to displace AlexaFluor-594-labelled CITED2 peptide from the pre-formed TAZ1-CITED2 complex (apparent K d = 0.9 ± 0.1 μ Μ , almost 100-fold weaker than the K d of the binary TAZ1-HIF-1α complex) ( Fig. 2d ).
To obtain further insights into the molecular mechanism of HIF-1α displacement by CITED2, stopped-flow fluorescence methods were used to measure the rates at which unlabelled HIF-1α or CITED2 peptides displace AlexaFluor-488-labelled HIF-1α peptide from its complex with unlabelled TAZ1. The difference in the kinetics of HIF-1α and CITED2 competition is notable ( Fig. 2e , f, Extended Data Figs 4, 5). CITED2 fully displaces labelled HIF-1α from TAZ1 within 10 s (observed rate (k obs ) = 2.2 ± 0.02 s −1 at 100 μ M competing CITED2) ( Fig. 2e , g, Extended Data Fig. 4 ), whereas unlabelled HIF-1α peptide fails to displace the fluorescently labelled HIF-1α in this time frame ( Fig. 2e , black curve). Instead, displacement by HIF-1α is slow (k obs = 0.04 ± 0.001 s −1 at 100 μ M competing HIF-1α ) and must be monitored by manual mixing experiments ( Fig. 2f , g, Extended Data Fig. 5 ). Competition by unlabelled HIF-1α peptide is only complete after 200 s, whereas competition by CITED2 is complete within the 10 s interval before data can be acquired (dead time) in the manual mixing experiment ( Fig. 2f , grey curve). The observed rate of dissociation of the fluorescently labelled HIF-1α peptide is directly proportional to the concentration of the competing CITED2 ( Fig. 2g , Extended Data Fig. 4b ), strongly suggesting that CITED2 forms a transient ternary complex with TAZ1 and HIF-1α , from which HIF-1α is displaced very rapidly. In the absence of ternary complex formation, dissociation of fluorescently labelled HIF-1α would be absolutely required before either unlabelled HIF-1α or CITED2 could bind, resulting in identical kinetic profiles for competition by both peptides. Thus, the efficient displacement of HIF-1α from its complex with TAZ1 by CITED2 is kinetically driven and proceeds through a transient ternary intermediate.
Conformational The colour scheme is as described in a. of the protein backbone, with higher NOE values corresponding to ordered regions and lower values indicative of dynamic disorder due to fluctuations on the picosecond-nanosecond timescale. Measurements of the { 1 H}-15 N NOE for the 15 N-HIF-1α and 15 N-CITED2 transactivation domains in complex with TAZ1 ( Fig. 3 ) show major differences in flexibility. HIF-1α displays a wide range of dynamics throughout its sequence (Fig. 3a ). The α B and α C helices adopt well-ordered, structured states with elevated heteronuclear NOE values, whereas the linker between α B and α C and residues in the N-terminal region, encompassing the α A helix and the LPQL motif, remain highly flexible. In contrast, the distribution of { 1 H}- 15 N NOE values is more uniform for residues 222-250 of the CITED2 peptide, with elevated values observed throughout the α A helix, the LPEL motif, and several neighbouring residues that form stabilizing interactions in the complex with TAZ1 ( Fig. 3b ).
HIF-1α and CITED2 form both well-ordered and dynamic contacts with TAZ1 ( Fig. 3 ), suggesting a critical role for disorder in modulating competition for TAZ1 binding. The α A helices of HIF-1α and CITED2 occupy the same surface of TAZ1 ( Fig. 1a ), but they exhibit different dynamic characteristics, with HIF-1α retaining considerable flexibility, whereas CITED2 adopts a stable, well-ordered helical structure ( Fig. 3 ). Complete dissociation of HIF-1α from the surface of TAZ1 is not a prerequisite for CITED2 binding; HIF-1α could remain anchored to TAZ1 through its α B and/or α C helices while allowing CITED2 to bind to the opposite face of TAZ1 through its α A helix, displacing the dynamically disordered α A helix of HIF-1α . Simultaneous binding of HIF-1α and CITED2 to TAZ1 would facilitate competition for binding at the common LP(Q/E)L site, providing a rational mechanism for the enhanced dissociation of HIF-1α in the presence of CITED2.
To determine the importance of the LP(Q/E)L motif in modulating competition between the HIF-1α and CITED2 transactivation domains, we designed a truncated CITED2 peptide (CITED2 (216-242)) encompassing the well-ordered α A helix but lacking the conserved LPEL motif (Fig. 4a ). Removal of the LPEL motif and the C-terminal residues results in a marked reduction in the TAZ1 binding affinity (K d, binary = 36 ± 10 μ M) (Extended Data Fig. 2c, g) . Similarly, a truncated HIF-1α peptide (HIF-1α (796-826)) lacking the α A region and LPQL motif ( Fig. 4a ) binds weakly to TAZ1 (K d, binary = 1.9 ± 0.1 μ M) (Extended Data Fig. 2d, g) . Despite the observed decrease in TAZ1 binding affinity for these truncated peptides, NMR spectra show that CITED2(216-242) and HIF-1α (796-826) bind to 15 N-TAZ1 in the same manner as the corresponding regions of the full-length CITED2 and HIF-1α peptides (Extended Data Fig. 6 ).
Direct evidence for ternary complex formation was obtained from NMR titrations ( Fig. 4, Extended Data Figs 7, 8 ). When unlabelled CITED2(216-242) peptide was added to a 1:1 complex of 15 N-TAZ1 with the full-length HIF-1α activation domain (residues 776-826), chemical shift changes and/or broadening were observed for HSQC cross peaks of TAZ1 residues located in the binding site of the CITED2 α A helix (Fig. 4b , Extended Data Figs 7, 9) , showing clearly that in the absence of the LPEL motif, the N-terminal region of the CITED2 peptide can bind to the TAZ1-HIF-1α complex without displacing the bound HIF-1α . The cross peaks of several residues in the C-terminal region of helix α 1 and in helix α 4 of TAZ1 are also perturbed by binding of the CITED2 peptide, shifting towards their positions in the spectrum of the TAZ1-CITED2 binary complex as excess peptide is added. These residues correspond to regions where there are differences in structure and relative helix orientation between the HIF-1α and CITED2 complexes (Extended Data Fig. 10 ). Binding of the truncated CITED2 (216-242) peptide to the pre-formed TAZ1-HIF-1α complex is relatively weak, as TAZ1 is in the HIF-1α -bound conformation (orange structure in Extended Data Fig. 10 ). Importantly, binding of the truncated HIF-1α peptide lacking the LPQL motif (HIF-1α (796-826)) to the TAZ1-CITED2 complex appears to be even weaker, with negligibly small changes observed in the HSQC spectrum of the 15 N-TAZ1-CITED2 complex on addition of a fivefold excess of HIF-1α peptide ( Fig. 4c , Extended Data Fig. 8 ), suggesting that the conformation of TAZ1 in complex with CITED2 (blue structure in Extended Data Fig. 10 ) does not favour binding of HIF-1α (796-826). This contrasts markedly with binding of HIF-1α (796-826) to free TAZ1, which occurs with a K d of 1.9 ± 0.1 μ Μ (Extended Data Fig. 2 ) and leads to large chemical shift changes in the TAZ1 HSQC spectrum (Extended Data Fig. 6 ). Thus, when TAZ1 is in the CITED2-bound conformation, the affinity for binding the α B -α C region of HIF-1α is greatly decreased.
Our data suggest that HIF-1α and CITED2 function synergistically, forming a hypersensitive unidirectional switch that stimulates release of HIF-1α from its complex with TAZ1 to maintain tight control of the transcriptional response to hypoxia. In the absence of such synergy, a large excess of CITED2 would be required to fully displace HIF-1α (hatched line in Fig. 2c) ; however, CITED2 fully displaces HIF-1α at close to equimolar concentration, creating a highly responsive feedback circuit. These data suggest a mechanistic model, illustrated schematically in Fig. 4d , that involves elements of direct competition, allostery and differential thermodynamic coupling between distinct binding motifs within the intrinsically disordered CITED2 and HIF-1α peptides. The apparent equilibrium constant for displacement of HIF-1α by CITED2 (K d,app = 0.2 nM) does not represent the affinity with which CITED2 binds to the TAZ1-HIF-1α complex, but is the product of the equilibrium constants for the individual steps. In this model, the CITED2 transactivation domain binds transiently to the TAZ1-HIF-1α complex through its N-terminal region, displacing the dynamic and weakly interacting α A helix of HIF-1α , then competing through an intramolecular process for binding to the LP(Q/E)L site. Plasticity in TAZ1 (denoted by changes in helix length and angle in Fig. 4d ) is vital to the operation of the allosteric switch. The CITED2 α A and LPEL motifs act cooperatively to strengthen the interactions between CITED2 and the TAZ1-HIF-1α complex, displace the HIF-1α LPQL motif, and shift the TAZ1 conformational ensemble towards the structure in the CITED2-bound state (Extended Data Fig. 10 ), thereby letter reSeArCH weakening the interactions with the α B and α C regions of HIF-1α and promoting rapid HIF-1α dissociation.
The unidirectional nature of the switch arises from differences in the strength of thermodynamic coupling 20 between distinct binding motifs in the HIF-1α and CITED2 peptides (denoted by Δ g H and Δ g C in Fig. 4d ). The α A and LPEL motifs of CITED2 are strongly coupled and function cooperatively as an integrated binding unit. The intervening amino acids have limited flexibility in the complex with TAZ1 (Fig. 3b) , forming a hydrophobic cluster that connects the α A and LPEL binding motifs and packs tightly against the TAZ1 surface. In contrast, the LPQL-α B and α C binding motifs of HIF-1α are separated by a highly dynamic linker in the TAZ1-HIF-1α complex (Fig. 3a) , resulting in weak coupling and limited binding cooperativity. The HIF-1α α B and α C regions bind extremely weakly to the TAZ1-CITED2 complex ( Fig. 4c ) and, as coupling between them is weak, HIF-1α is ineffective in displacing CITED2 from the TAZ1-CITED2 complex.
Fine-tuning of transcriptional output is especially critical in the case of hypoxia as cells must respond rapidly to changes in oxygen levels and uncontrolled expression of oxygen stress genes would lead to unacceptable levels of tissue damage. Here we show that HIF-1α and CITED2 function as a fine-tuned molecular on/off switch for the hypoxic response. This function is entirely dependent on their intrinsic disorder, which allows them to undergo energetically and dynamically heterogeneous interactions with their common target, the TAZ1 domain of CBP/p300. The unique characteristics of intrinsically disordered proteins make them well-suited for allosteric regulation of cellular signalling 21-23 . Given the prevalence of disorder in the proteome and the pleiotropic nature of molecular hub proteins such as CBP/p300 (refs 10, 11), we anticipate that the mechanism described here may represent a general regulatory strategy used by intrinsically disordered proteins to compete for binding of common molecular targets in response to specific stimuli throughout the cell cycle. The existence of such allosteric regulatory mechanisms has important implications for systems biology, since computational modelling of cellular networks on the basis of widely available binary dissociation constants would be invalid when allostery is involved.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. The cyan, gold, orange and magenta spectra cross peaks are almost exactly superimposed. d, Schematic mechanism for displacement of HIF-1α from its complex with TAZ1 by CITED2. The α 1, α 3 and α 4 helices of TAZ1 are represented as grey cylinders, HIF-1α is shown in orange, and CITED2 in blue. Δ g C and Δ g H represent thermodynamic coupling between the α A and LPEL motifs of CITED2 and between the LPQL-α B and α C motifs of HIF-1α , respectively.
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MethOds
Protein preparation. All HIF-1α and CITED2 constructs (HIF-1α residues 776-826; HIF-1α residues 796-826; CITED2 residues 216-269; CITED2 residues 216-242) were expressed in E. coli BL21 (DE3) (DNAY) as His 6 -tagged GB1 fusion proteins in a coexpression vector with TAZ1 (residues 340-439 of mouse CBP) 24 . Cell pellets were resuspended in 40 ml of buffer containing 25 mM Tris (pH 8.0), 200 mM NaCl, 8 M urea, and 20 mM imidazole per litre of culture and lysed by sonication. The soluble fraction was isolated by centrifugation. The supernatant was purified by nickel affinity chromatography using NiNTA resin and the HIF-1α and CITED2 peptides were separated from the His 6 -GB1 tag by thrombin cleavage on the resin. The cleaved HIF-1α and CITED2 peptides were further purified by reversed phase HPLC, using a C4 cartridge (Waters) in standard acetonitrile/TFA mobile phase. Pure HIF-1α and CITED2 peptides were lyophilized and stored at − 80 °C. Lyophilized peptides were dissolved in 50-100 mM Tris buffer (pH 8) and dialysed overnight in buffer containing 20 mM Tris (pH 6.8), 50 mM NaCl, and 2 mM dithiothreitol (DTT) before use. TAZ1 was expressed and purified under native conditions as described previously 25 , with additional purity achieved by size-exclusion chromatography on a Superdex 75 column (GE Healthcare) in buffer containing 20 mM Tris (pH 8.0), 200 mM NaCl, and 2 mM DTT. Uniform isotopic labelling of 15 N-HIF-1α , 15 N-CITED2, and 15 N-TAZ1 for NMR experiments was performed by expression in minimal media containing 15 N ammonium chloride (0.5 g l −1 ) and 15 N ammonium sulfate (0.5 g l −1 ) as the sole nitrogen sources.
HIF-1α constructs for fluorescence experiments required additional mutations to allow single-site labelling. The full-length HIF-1α transactivation domain construct (residues 776-826) contains two cysteine residues at positions 780 and 800. A non-perturbing C800V point mutation 26 was introduced to allow for fluorescent labelling of HIF-1α at position 780. The native sequence of the truncated HIF-1α construct (residues 796-826) does not contain any cysteine residues. The HIF-1α C terminus was extended by three residues (Gly-Ser-Cys) to introduce an exposed cysteine residue for labelling. In this extended HIF-1α truncation construct, the C-terminal residue of HIF-1α (Asn826) was mutated to Asp to preserve the native negative charge in this region. All single-Cys HIF-1α mutants were labelled with a 3-5-fold molar excess of AlexaFluor 488 or AlexaFluor 594 maleimide dye (Molecular Probes) in 50 mM Tris (pH 7.2), 2 mM TCEP. The labelling reaction was carried out overnight at 4 °C. Dye-labelled HIF-1α peptides were separated from free dye and unlabelled peptide on an analytical C18 reverse-phase HPLC column. Full-length CITED2 was labelled with AlexaFluor 488 or 594 at Cys 261 in the same manner.
GST-TAZ1 for bio-layer interferometry assays was obtained by cloning the TAZ1 sequence (mouse CBP residues 340-439) into the pGEX-4T2 vector. Soluble GST-TAZ1 was purified by affinity chromatography on a glutathione sepharose 4B column followed by size-exclusion chromatography on a Superdex 75 column (GE Healthcare). Concentration measurements. Protein concentrations were determined by absorbance at 280 nm. For CITED2(216-242), which does not contain tyrosine or tryptophan residues, concentrations were determined by absorbance at 205 nm 27 . To ensure that concentrations determined from absorbance measurements at 280 nm and 205 nm are in agreement, we measured the absorbance at both wavelengths for proteins containing tryptophan and tyrosine residues. Protein concentrations determined by both methods were in excellent agreement, with less than 5% variation between concentrations determined by absorbance at 280 nm and 205 nm. NMR spectroscopy. All NMR samples were prepared in buffer containing 20 mM Tris (pH 6.8), 50 mM NaCl, 2 mM DTT, and 5% D 2 O. Spectra were recorded at 25 °C on Bruker 500, 600 and 900 MHz spectrometers. NMR data were processed using NMRPipe 28 and analysed using SPARKY 29 . Heteronuclear NOE measurements 30 were carried out in triplicate in a fully interleaved manner on a Bruker DRX 600 MHz spectrometer equipped with a cryo-probe. Bio-layer interferometry. Bio-layer interferometry experiments were performed using an Octet RED96 instrument (ForteBio) at 25 °C in buffer containing 20 mM Tris (pH 6.8), 50 mM NaCl, and 2 mM DTT. Anti-GST biosensors (ForteBio) were pre-equilibrated in buffer for 10 min before each experiment. Optimal sensor loading was achieved using 25 μ g ml −1 GST-TAZ1 and a loading period of 2 min. Dissociation constants (K d ) were determined from binding data obtained with at least three concentrations of HIF-1α or CITED2 peptide. The data were analysed using the global fitting algorithm included in the Octet Data Analysis Software 7.0 (ForteBio). Fluorescence anisotropy. Fluorescence anisotropy binding and competition assays were carried out in buffer containing 20 mM Tris (pH 6.8), 50 mM NaCl, and 2 mM DTT at 25 °C on an ISS-PC1 photon-counting steady-state fluorimeter.
Dissociation constants (K d ) for HIF-1α (776-826), CITED2(216-269), and CITED2(216-242) binding to TAZ1 were determined by a competition method 18, 19 to enable detection of high-affinity binding and account for any effects of labelling. In this method, 20 nM labelled HIF-1α (776-826) or CITED2(216-269) was initially bound to 250 nM TAZ1. Unlabelled HIF-1α and CITED2 peptides were titrated into the pre-formed complex of labelled peptide with TAZ1 and anisotropy of the fluorescent HIF-1α or CITED2 peptide was recorded at each concentration of competing unlabelled peptide. Data were fit as previously described 18, 19 using Prism 7.0 (GraphPad Software, Inc.). HIF-1α (796-826) was labelled as described above and unlabelled TAZ1 was titrated directly into a cuvette containing 20 nM fluorescent-labelled HIF-1α (796-826). Anisotropy measurements were carried out after each addition of TAZ1 and the data were fit to a standard one-site binding model using Prism 7.0 (GraphPad Software, Inc.). Anisotropy measurements were carried out three times using different protein preparations. Each competition experiment was performed under carefully controlled conditions, using the same stock solutions of CITED2 and HIF-1α peptides to displace bound, fluorescently labelled CITED2 and HIF-1α peptides from TAZ1. In this way potential errors arising from slight variations in peptide concentration are eliminated. Reported anisotropy values are the average of the three independent measurements, with error bars depicting the standard deviation. Time-resolved fluorescence measurements. Kinetic curves describing the competition of unlabelled HIF-1α and CITED2 peptides (12.5-100 μ M, after mixing) with a pre-formed complex of AlexaFluor-488-labelled HIF-1α peptide and unlabelled TAZ1 (0.25 μ M after mixing) were obtained by measuring the fluorescence intensity of the labelled HIF-1α peptide as a function of time after mixing with the competing unlabelled peptide. All samples were prepared in buffer containing 20 mM Tris (pH 6.8), 50 mM NaCl, and 2 mM DTT. For manual mixing fluorescence experiments, samples were mixed by hand in a quartz cuvette and kinetic traces were obtained by monitoring the fluorescence intensity at 517 nm with an excitation wavelength of 494 nm for 200 s on an ISS-PC1 photon-counting steadystate fluorimeter. The delay between mixing and fluorescence detection was 10 s. Observed rates (k obs ) were obtained by fitting the kinetic traces to a single exponential decay function using Prism 7.0 (GraphPad Software, Inc.). Each curve was measured three times and reported rates are the average and standard deviation of the three independent measurements.
Stopped-flow kinetic traces were obtained using an Applied Photophysics DX-17 stopped flow spectrophotometer operating at 25 °C. Fluorescence intensity was measured for 1-10 s after rapid mixing using an excitation wavelength of 488 nm and a 515 nm long-pass cutoff filter for AlexaFluor-488-labelled samples. Data collected in the first 2 ms were removed before fitting to account for the instrumental dead time. 5-10 kinetic traces were averaged and the data were fit to a single exponential decay function using Prism 7.0 (GraphPad Software, Inc.). Data at each concentration of peptide were measured three times and the reported rates are the average and standard deviation of the three independent measurements. Data availability. All structures referred to in this work have been previously published 5, 8, 25 
